Abstract
Purpose
A quality of life (QoL) assessment is considered an important outcome measure in the treatment of benign thyroid diseases. The aims of this study were to analyze the impact of different surgical treatments on QoL in patients with benign thyroid diseases and to evaluate factors correlating with the QoL outcomes.
Methods
A prospective longitudinal study was conducted. One hundred thirty-two patients met the inclusion/exclusion criteria and completed the disease-specific questionnaire, thyroid patient-reported outcome (ThyPRO), before surgery and after 6 months. Preoperative and postoperative QoL outcomes were compared and correlating factors were analyzed.
Results
Indication for surgery was euthyroid goiter, toxic goiter, and suspicious malignant thyroid disease in 58.3, 29.5, and 12.1 % of the patients, respectively. None of the patients had overtly toxic goiter. There were 65.2 % of the patients who underwent total thyroidectomy, while 34.8 % underwent hemithyroidectomy. The total postoperative complication rate was 5.3 %. QoL improved significantly after surgical treatment, independent of the extent of performed surgery. The most affected domain, pre- and postoperative, was for tiredness. QoL improvement was significant for women in all domains, while for men, it was significant in only three domains (goiter symptoms, emotional susceptibility, and cosmetic complaints) and in overall QoL. Younger patients had significantly better cognitive functioning and daily life, while elderly patients had significantly less cosmetic complaints. The factors that significantly correlated with improvement of QoL in different domains were lower education level, duration of disease, and microcarcinoma at final histology.
Conclusion
QoL in patients with benign thyroid diseases improves significantly after operative treatment, independent of the extent of the operation.
Similar content being viewed by others
References
Wang C, Crapo LM (1997) The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin N Am 26(1):189–218
Jankovic R (2001) Hirurgija tiroidne i paratiroidnih zlezda. Zavod za udzbenike i nastavna sredstva, Beograd (serb)
Bukvic B, Sipetis S, Kalezic N, Diklic A, Paunovic I, Kovacevic B, Knezevic A, Zivaljevic V (2011) Changing trends in mortality of thyroid cancer in Belgrade population. JBUON 16(2):337–340
Velanovich V (2007) Using quality-of-life measurements in clinical practice. Surgery 141(2):127–133
Bianchi PG, Zaccheroni V, Solaroli E, Vescini F, Cerutti R, Zoli M, Marchesini G (2004) Health-related quality of life in patients with thyroid disorders. Qual Life Res 13:45–54
Watt T, Groenvold M, Rasmussen KA, Bonnema JS, Hegedus L, Bjorner BJ, Feldt-Rasmussen U (2006) Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 154(4):501–510. doi:10.1530/eje.1.02124
Hays DR (2005) Generic versus disease-target instruments. In: Feyers P, Hays R (eds) Assessing quality of life in clinical trials, 2nd edn. Oxford University Press, Oxford, pp 3–8
Watt T, Hegedus L, Rasmussen KA, Groenvol M, Bonnema JS, Bjorner BJ, Feldt-Rasmussen U (2007) Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide complementary perspectives. Thyroid 17:647–654. doi:10.1089/thy.2007.0069
Watt T, Rasmussen KA, Groenvold M, Bjorner BJ, Watt HS, Bonnema JS, Hegedus L, Feldt-Rasmussen U (2008) Improving a newly developed patient-reports outcome for thyroid patients, using cognitive interviewing. Qual Life Res 17:1009–1017. doi:10.1007/s11136-008-9364-z
Watt T, Bjorner BJ, Groenvold M, Rasmussen KA, Bonnema JS, Hegedus L, Feldt-Rasmussen U (2009) Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination. Qual Life Res 18:483–496. doi:10.1007/s11136-009-9460-8
Watt T, Hegedus L, Groenvold M, Bjorner BJ, Rasmussen KA, Bonnema JS, Feldt-Rasmussen U (2010) Validity and reliability of the novel thyroid-specific quality of lie questionnaire. Eur J Endocrinol 162:161–167. doi:10.1530/EJE-09-0521
Husson O, Haak RH, Oranjes AW, Mols F, Reemst HMP, van de Poll-Franse VL (2011) Health-related quality of life among thyroid cancer survivors: a systematic review. Clin Endrocinol 75:544–554. doi:10.1111/j. 1365-2265.2011.04114.x
Eustatia-Rutten CFA, Corssmit EPM, Pereira AM, Frolich M, Bax JJ, Romijn JA, Smit JWA (2006) Quality of life in long-term exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomized controlled trial. Clin Endocrinol 64(3):284–291. doi:10.1111/j.1365-2265.2006.02458.x
Hoftijzer HC, Heemstra KA, Crossmit EP, van der Klaauw AA, Romijn JA, Smit JW (2008) Quality of life cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93(1):200–203
Simon NM, Blacker D, Korbly NB, Sharma SG, Worthington JJ, Otto MW, Pollack MH (2002) Hypothyroidism and hyperthyroidism in anxiety disorder revisited: new data and literature review. J Affect Disord 69:201–217
Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W, Gorges R (2006) Health-related quality of life, depression and anxiety in thyroid cancer patients. Qual Life Res 15(4):695–703
Abraham-Nordling M, Wallin G, Lundell G, Torring O (2007) Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves’ disease. Eur J Endocrinol 156(2):173–179
Scerrino G, Morfino G, Paladino NC, Di Paola V, Amodio E, Gulotta G, Bonventre S (2013) Does thyroid surgery for Graves’ disease improve health-related quality of life? Surg Today 43(12):1398–1405. doi:10.1007/s00595-012-0442-z
Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G (2004) Impaired health-related quality of life in Graves’ disease. A prospective study. Eur J Endocrinol 151(5):549–555
Ott J, Prombereger R, Kober F, Neuhold N, Tea M, Huber JC, Hermann M (2011) Hashimoto’s thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 21(2):161–167. doi:10.1089/thy.2010.0191
Promberger R, Hermann M, Pallikunnel SJ, Seemann R, Meusel M, Ott J (2013) Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto’s thyroiditis. Am J Surg. doi:10.1016/j.amjsurg.2013.05.005
Miccoli P, Minuto MN, Paggini R, Rucci P, Oppo A, Donatini G, Golia F, Novelli L, Carlini M, Dell’Osso L (2007) The impact of thyroidectomy on psychiatric symptoms and quality of life. J Endocrinol Investig 30(10):853–859
Schmitz-Winnenthal FH, Schimmack S, Lawrence B, Maier U, Heidmann M, Buchler WM, von Frankenberg M (2011) Quality of life is not influenced by the extent of surgery in patients with benign goiter. Langenbeck’s Arch Surg 396:1157–1163. doi:10.1007/s00423-011-0822-7
Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A, Verma KA, Mishra KS (2013) Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study. World J Surg 37:2322–2329. doi:10.1007/s00268-013-2133-3
Marquis P, Keininger D, Acquadro C, de la Loge C (2005) Translating and evaluating questionnaires: cultural issues for international research. In: Feyers P, Hays R (eds) Assessing quality of life in clinical trials, 2nd edn. Oxford University Press, Oxford, pp 77–92
Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B (2005) Depression, anxiety, health-related quality of life and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 37:133–139. doi:10.1016/j.arcmed.2005.05.008
Bukvic B, Sipetic S, Stanisavljevic D, Paunovic I, Diklic A, Tausanovic K, Zivaljevic V (2014) Quality of life, anxiety and depression in patients with thyroid diseases and correlating factors. Acta Med Mediterr 30:731–736
Klaver EI, van Loon HC, StienstraR LTP, Keers JC, Kema IP, Kobold AC, van der Klauw MM, Wolffenbuttel BH (2013) Thyroid hormone status and health-related quality of life in the lifelines cohort study. Thyroid 23(9):1066–1073. doi:10.1089/thy.2013.0017
Biondi B, Palmieri AE, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G, Perticone F (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85:4701–4705
Pacini F (2012) Thyroid microcarcinoma. Best Pract Res Clin Endocrinol Metab 26(4):421–429. doi:10.1016/j.beem.2011.10.006
Watt T, Hegedüs L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, Feldt-Rasmussen U (2012) Is thyroid autoimmunity per se a determinant of quality of life in patients with autoimmune hypothyroidism? Eur Thyroid J 1(3):186–192. doi:10.1159/000342623
Acknowledgments
This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 175 042). We also thank Torquil Watt, the developer of ThyPRO questionnaire, for collaboration in the translation process and for permitting us to use the questionnaire in the study.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bukvic, B.R., Zivaljevic, V.R., Sipetic, S.B. et al. Improvement of quality of life in patients with benign goiter after surgical treatment. Langenbecks Arch Surg 399, 755–764 (2014). https://doi.org/10.1007/s00423-014-1221-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-014-1221-7